Meridian Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Sell
1,114
-9
-0.8% -$9.2K 0.44% 49
2026
Q1
$1.05M Sell
1,123
-2
-0.2% -$2.03K 0.4% 54
2025
Q4
$1.21M Sell
1,125
-15
-1% -$14.3K 0.48% 46
2025
Q3
$964K Buy
1,140
+67
+6% +$49.9K 0.4% 52
2025
Q2
$836K Buy
1,073
+26
+2% +$20.2K 0.39% 55
2025
Q1
$865K Buy
+1,047
New +$871K 0.44% 51

Other funds holding LLY

Meridian Financial Partners's LLY Position: Q2 2026 in Review

Meridian Financial Partners reduced its Eli Lilly (LLY) stake by 0.8% in Q2 2026, selling an estimated $9.2K and leaving 1,114 shares worth $1.29M. The position accounts for 0.44% of the portfolio, ranked #49.

Meridian Financial Partners first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,857 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Meridian Financial Partners held 1,114 shares of Eli Lilly worth $1.29M as of Q2 2026.
  • Meridian Financial Partners sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.44% of Meridian Financial Partners's portfolio in Q2 2026, its #49 holding.
  • Meridian Financial Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,857 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Meridian Financial Partners's 13F filing for Q2 2026, filed 24 Jul 2026.